Emerald Advisers’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $249K | Buy |
|
|||||
|
2025
Q1 | $263K | Sell |
|
|||||
|
2024
Q4 | $675K | Sell |
|
|||||
|
2024
Q3 | $692K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $311K | Sell |
|
|||||
|
2023
Q2 | $1.32M | Sell |
|
|||||
|
2023
Q1 | $17.5M | Sell |
|
|||||
|
2022
Q4 | $26.3M | Buy |
|
|||||
|
2022
Q3 | $19.5M | Sell |
|
|||||
|
2022
Q2 | $37.7M | Sell |
|
|||||
|
2022
Q1 | $36.5M | Buy |
|
|||||
|
2021
Q4 | $40.2M | Sell |
|
|||||
|
2021
Q3 | $35M | Buy |
|
|||||
|
2021
Q2 | $33.6M | Sell |
|
|||||
|
2021
Q1 | $32.5M | Sell |
|
|||||
|
2020
Q4 | $32.3M | Buy |
|
|||||
|
2020
Q3 | $19.5M | Sell |
|
|||||
|
2020
Q2 | $24M | Buy |
|
|||||
|
2020
Q1 | $12.3M | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $886K | Sell |
|
|||||
|
2015
Q2 | $1.18M | Sell |
|
|||||
|
2015
Q1 | $2.13M | Sell |
|
|||||
|
2014
Q4 | $2.62M | Buy |
|